about
Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrusInterleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain modelSeqinspector: position-based navigation through the ChIP-seq data landscape to identify gene expression regulators.Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypesKainic Acid Induces mTORC1-Dependent Expression of Elmo1 in Hippocampal Neurons.Identification of cis-regulatory elements in the mammalian genome: the cREMaG databaseCREB activity in dopamine D1 receptor expressing neurons regulates cocaine-induced behavioral effectsExpression profiling of genes modulated by minocycline in a rat model of neuropathic painFull inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.Mechanisms of Attenuation of Pulmonary V'O2 Slow Component in Humans after Prolonged Endurance Training.Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant actionMorphine effects on striatal transcriptome in mice.Gene expression profiling of blood in ruptured intracranial aneurysms: in search of biomarkersThe dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum.Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation?Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state.Opioid-dependent regulation of high and low fear responses in two inbred mouse strains.Susceptibility and resilience to stress - Endophenotypes and molecular markers in two inbred mouse strains.The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.Regulation of ERK1/2 phosphorylation by acute and chronic morphine - implications for the role of cAMP-responsive element binding factor (CREB)-dependent and Ets-like protein-1 (Elk-1)-dependent transcription; small interfering RNA-based strategy.Regulation of alternative gene transcription in the striatum in response to antidepressant drugs.Neuropsin cleaves EphB2 in the amygdala to control anxiety.GABA-A receptor genes do not play a role in genetics of Lesch's typology in Caucasian subjects.A polymorphism in exon 2 of the delta-opioid receptor affects nociception in response to specific agonists and antagonists in mice selectively bred for high and low analgesia.Corrigendum: CREB activity in dopamine D1 receptor expressing neurons regulates cocaine-induced behavioral effectsDifferential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain.Cocaine enhances ST8SiaII mRNA expression and neural cell adhesion molecule polysialylation in the rat medial prefrontal cortex.Association between the A107V substitution in the δ-opioid receptors and ethanol drinking in mice selected for high and low analgesia.Behavioral and transcriptional patterns of protracted opioid self-administration in mice.Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.High-throughput gene expression profiling of opioid-induced alterations in discrete brain areas.Effects of morphine on immediate-early gene expression in the striatum of C57BL/6J and DBA/2J mice.Endogenous opioids regulate glucocorticoid-dependent stress-coping strategies in mice.Genotype-dependent consequences of traumatic stress in four inbred mouse strains.Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine.New operant model of reinstatement of food-seeking behavior in mice.The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord.Astrocytes are a neural target of morphine action via glucocorticoid receptor-dependent signaling.Expression of alternatively spliced variants of the Dclk1 gene is regulated by psychotropic drugs
P50
Q27311267-5EF5D809-4CC5-411A-A4E7-FFBE843FFAACQ28571428-E3DD4AD0-84A8-452C-92B4-28722D460959Q31044437-DD59AD6F-502F-46F5-91C5-56ADE62240D7Q33246682-E339C966-634E-45DF-A939-21BB7A64629AQ33559297-4103FDCE-0D57-4D1D-9F56-087D774138F4Q33687266-AF490826-6B0D-4CF0-B344-277FFF2C47D1Q33738802-6272EB46-D947-4E46-A7B2-B1722E59E359Q34039604-233CC615-C6E8-46AA-8CAD-28EAA4DDABD0Q34661844-480A5E68-821D-4F8D-9CB4-B5A69783B953Q34980328-D5B707D6-3F37-43DE-9C8F-00025F0F2D06Q35996773-987AEF27-761D-4DF5-9D29-66676C519795Q36020138-90E9AB2A-3BB0-4D5F-AAC9-81621B165B6BQ36672435-495A5382-51BD-4D55-BCBF-574F9FBF3E94Q36994302-DA0B4B1B-2C14-4600-9F65-87C49DCE4C4FQ38344063-739B5609-3417-4B4D-8FDF-4C2D879302AAQ38507815-0763F237-827F-4D48-8A77-B06EE4B49C4FQ39006365-F38F0180-BF0A-4FCE-9298-F7A660164B44Q39278021-2BFFD8E8-3CE2-4956-830D-341442C2CAE6Q39281717-80A2C76B-F7C7-4253-A4F5-94FCAD7AF7D2Q39417327-8491DB91-6D1F-469E-B44F-84591E040138Q39963045-3E50D238-2C69-4C40-ABDF-C247F87BA3DCQ40645554-5D0B1474-7FDE-4AB6-A627-C930C9C705BFQ41962381-EA0AC2EF-A4D1-446A-9ACA-2FDAE9780924Q42178036-8C99AE67-ACCB-4142-9185-779F5B0F869CQ42470052-A1274E5C-5345-4F38-9960-792E692A3A7FQ42727319-EC509EB0-02B9-462E-A994-5192DB872959Q43274323-F4D5F761-0CE5-4359-9801-6CDC869383A0Q44125340-04273370-BE45-4D2B-95D8-C4A445D4A617Q44138508-BA7C60C8-291C-42CB-8055-E434934CE262Q44339836-44B13626-2EDA-4C33-BBBE-EADC5377374BQ44341214-FDDEB871-3381-4A71-8822-B9D0CF956D17Q44347560-1B926B9E-3A0A-4B99-8476-F64075EFA5FAQ45085769-A1380BF8-7BA4-49EA-A0B7-BF0AFF870D5AQ46541075-DFB8A840-9BFE-4D0C-9073-B68E0FCE24DBQ48378890-2E2A64D4-039A-4729-9E3E-0566F5BB9F05Q48628774-9C9C34F3-1696-48CC-B79A-686D35716556Q51893298-A2F61B4F-2A94-4BDB-A3DA-F891CCF6EDA2Q54400055-8D1BE69E-36AC-40F1-86EF-53BB2D0EF42EQ54455120-974CC179-8A34-43C5-BEF8-ADA8B883364AQ58748155-07663D0A-660E-48C4-AEEF-D1F033D9FDEC
P50
description
Polish pharmacologist
@en
Pools farmacoloog
@nl
polski farmakolog
@pl
name
Michał Korostyński
@ast
Michał Korostyński
@ca
Michał Korostyński
@cs
Michał Korostyński
@en
Michał Korostyński
@es
Michał Korostyński
@gl
Michał Korostyński
@hr
Michał Korostyński
@hsb
Michał Korostyński
@it
Michał Korostyński
@nl
type
label
Michał Korostyński
@ast
Michał Korostyński
@ca
Michał Korostyński
@cs
Michał Korostyński
@en
Michał Korostyński
@es
Michał Korostyński
@gl
Michał Korostyński
@hr
Michał Korostyński
@hsb
Michał Korostyński
@it
Michał Korostyński
@nl
prefLabel
Michał Korostyński
@ast
Michał Korostyński
@ca
Michał Korostyński
@cs
Michał Korostyński
@en
Michał Korostyński
@es
Michał Korostyński
@gl
Michał Korostyński
@hr
Michał Korostyński
@hsb
Michał Korostyński
@it
Michał Korostyński
@nl
P214
P106
P1412
P1559
Michał Korostyński
@pl
P21
P214
P27
P31
P3124
P735
P7859
viaf-311811721